Investors
16950
page-template-default,page,page-id-16950,bridge-core-1.0.6,ajax_fade,page_not_loaded,,qode_grid_1200,qode-theme-ver-18.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.4.1,vc_responsive
 

Investors

Investors

Cantex has raised a total of $62 million to date, including investments from the following firms and individuals.

Domain Associates
Hepalink
Aurora Funds
Neil Flanzaich, M.D., CEO - Cantex Pharmaceuticals
Neil W. Flanzraich
Executive Chairman
Cantex Pharmaceuticals, Inc.